Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

carboplatin-Taxol-bevacizumab regimen

(KAR-boh-pla-tin-TAK-sol-beh-vuh-SIH-zoo-mab REH-jih-men)
A chemotherapy combination used to treat advanced, nonsquamous non-small cell lung cancer. It includes the drugs carboplatin, paclitaxel (Taxol), and bevacizumab. Also called carboplatin-paclitaxel-bevacizumab regimen.
Search NCI's Dictionary of Cancer Terms